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Abstract 
Title: The Use of Regional Anesthesia with Paravertebral Nerve Block and its Effects on Cancer 
Recurrence and Metastasis 
Background: Surgical removal of breast cancer remains a mainstay treatment. The use of 
regional anesthesia may be associated with improved long-term outcomes and lower rates of 
recurrence and metastasis. Regional anesthesia attenuates the body’s surgical stress response, 
reduces immunosuppression and need for opioid and general anesthetic consumption.  
Purpose: The purpose of this independent project is to review the current literature regarding the 
effect regional anesthesia has on recurrence or metastasis of breast cancer after tumor removal 
surgery.  
Process: A comprehensive review of the literature was performed utilizing CINAHL and 
PubMed databases from the University of North Dakota’s Health Sciences Library. Each  
reference was carefully selected, reviewed, and applied.  
Results: It was determined inconclusive as to whether regional anesthesia improves rates of 
breast cancer recurrence or metastasis. The use of regional anesthesia has been associated with  
lower levels of inflammation and better immune response when compared to general anesthesia  
and opioid use. 
Implications: A majority of the research to date has been small retrospective studies. A large  
randomized control trial is currently underway, which may strengthen evidence and practice  
recommendations.  
Keywords: Regional anesthesia, breast cancer, metastasis, neoplasm, neoplasm metastasis, and  
anesthesia conduction. 
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The Use of Regional Anesthesia with a Paravertebral Nerve Block and its Effects on Cancer 
Recurrence and Metastasis 
The American Cancer Society (2018) reports that breast cancer remains the most 
common cancer, (besides skin cancer) and the second leading cause of cancer death among 
American women. One in eight women will develop breast cancer during her lifetime. In 2018, 
over 330,000 new cases of breast cancer will be diagnosed. Typical treatment for breast cancer is 
surgical tumor removal. Depending on how advanced the cancer is, treatment may also include 
chemotherapy, radiation and hormone therapy (American Cancer Society, 2018). An estimated 
30-40% of patients who develop metastatic recurrence of breast cancer will die despite treatment 
(Pérez-González, Cuéllar-Guzmán, Soliz, & Cata, 2017). Despite the attempts to remove the 
cancer cells along with adjuvant therapies, metastatic disease remains a significant cause of death 
(Xuan, Hankin, Zhao, Yao, & Ma, 2014). Anesthesia providers are caring for and providing 
anesthesia for cancer patients daily. Since 2006 the question has been posed as to whether the 
anesthetic technique used during tumor removal surgical procedures influence the metastasis of 
cancer (Barela & Welliver, 2017). 
The perioperative period is a critical time in the prognosis of long-term outcomes in 
breast cancer. The use of regional anesthesia has been hypothesized to improve breast cancer 
recurrence and metastasis (Sessler, Shamgar, Mascha, Parat, & Buggy, 2017). During surgical 
intervention of tumor resection, cancer cells can be inadvertently disseminated into the 
circulation, increasing the risk for metastasis (Sessler et al., 2017). The surgical stress response is 
also activated, which contributes to postoperative immunosuppression (Xuan et al., 2014). 
According to Barela and Welliver (2017), “the stress of surgery results in a neuroendocrine 
response, depressing the immune system, causing a decrease in cell-mediated immunity” (p. 75). 
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The use of opioids and volatile anesthetics can worsen immunosuppression, putting the patient at 
a higher risk for cancer growth (Barela & Welliver, 2017). Local anesthetics and regional 
anesthesia have been shown to reduce local inflammation at the surgical site, attenuating the 
immunosuppression (Barela & Welliver, 2017). Regional anesthesia significantly reduces the 
amount of general anesthetic required and provides excellent pain relief during the intraoperative 
and postoperative periods requiring little to no use of opioids and avoiding their adverse effects 
on the immune function (Karmakar et al., 2017). 
Breast cancer affects a sizable portion of the population. New advances and research are 
continually being conducted to improve outcomes. Anesthesia is part of the care these patients 
require.  The following pages include a case report of a patient undergoing a mastectomy due to 
diagnosed breast cancer, review of the literature including pathophysiology, pharmacology and 
results from recent studies conducted on the outcome of patients with breast cancer.  
Purpose 
The purpose of this independent project is to review a case report and provide anesthesia 
professionals with evidence-based research regarding long-term outcomes of anesthetic 
technique used for breast cancer tumor removal surgeries. The effects of surgery, general 
anesthetics, and medications at a cellular level, has been hypothesized to affect the recurrence 
and metastasis of cancer. Being aware of the alternate choices to general anesthesia may affect 
the long-term prognosis of the patients’ cancer diagnosis.  
Case Report 
 A 64-year-old, 71 kilograms (kg), 160 centimeters (cm), Caucasian female presented for 
a right modified radical mastectomy with axillary sentinel lymph node dissection for the 
treatment of invasive ductal carcinoma of the right breast. She had allergies to prednisone and 
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exposure to environmental factors. Her medical history included asthma, fibromyalgia, hiatal 
hernia, hypokalemia, urinary tract infection, hypomagnesemia, invasive ductal carcinoma of the 
right breast, antineoplastic chemotherapy, chemotherapy-induced diarrhea, neutropenia, drug-
induced pancytopenia, sepsis and neutropenic fever. Surgical history included sinus surgery, 
knee arthroscopy, colon polyp biopsy, venous access insertion, hysterectomy, carpal tunnel 
release and upper endoscopy. There was no history of anesthetic complications. Her medications 
included fluticasone, dronabinol, prochlorperazine, tramadol, ondansetron, dexamethasone, 
pantoprazole, azelastine, multi-vitamin, calcium, magnesium, zinc, ipratropium 
bromide/albuterol nebulizer, acetaminophen, vitamin D3 – cholecalciferol and nasal moisturizer.  
 The patient was considered an American Society of Anesthesiologists physical status 
level three with a Mallampati class II. Bilateral breath sounds were clear to auscultation, and 
preoperative electrocardiogram (EKG) revealed sinus tachycardia at 102 beats per minute 
(BPM). Preoperative vital signs were: heart rate 98 BPM, blood pressure 139/92 mmHg, 
respirations 18/minute, pulse oximetry 98% on room air, and temperature 97.7° Fahrenheit (F). 
A peripheral intravenous line was started by the nurse in the holding room, and 2 milligrams 
midazolam (mg) intravenously (IV) was administered. The patient was then transported to the 
operating room where she was assisted onto the operating table. Non-invasive monitors were 
applied which included: a finger pulse oximeter, a 5-lead electrocardiogram (EKG), and a blood 
pressure cuff.  
 The patient was given two puffs of an albuterol inhaler and then pre-oxygenated via 
facemask at 8 liters per minute. Vital signs were: heart rate 105 BPM, blood pressure 147/96 
mmHg, and pulse oximetry of 100%. One hundred micrograms (mcg) of fentanyl, 50 mg of 
lidocaine, and 150 mg of propofol were all given IV for induction. The ability to ventilate was 
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confirmed with chest rise, end-tidal carbon dioxide (ETCO2) and mask fogging. Subsequently, 
30 mg rocuronium IV was administered for relaxation. A 7.0 cuffed endotracheal tube (ETT) 
was placed by direct laryngoscopy utilizing a Macintosh three blade with a grade one Cormack 
and Lehane view. After intubation, bilateral breath sounds were auscultated, ETCO2 monitoring 
was present, and the ETT was secured at 21 centimeters (cm) at the lip. The patient was placed 
on volume control mode with a rate of 12/min, and a tidal volume of 500 mL as well as initiating 
sevoflurane to achieve a half MAC at 1%. Inspired oxygen was titrated to 50%, and the air was 
administered to keep total flows at 2 liters (L) per minute. The patient's blood pressure increased 
to 162/101 mmHg during induction, an additional 50 mcg of fentanyl IV was administered, and a 
propofol infusion was started at 80 mcg/kg/min. A nasopharyngeal probe was inserted for 
temperature monitoring with a temperature of 97.5°F throughout the procedure. The patient’s 
blood pressure decreased to 87/39 mmHg. Therefore, 100 mcg of phenylephrine IV was 
administered, followed by another 100 mcg of phenylephrine IV three minutes later for a blood 
pressure of 92/40 mmHg. Two grams (g) of cefazolin IV was administered for a preoperative 
antibiotic. Ten milligrams of dexamethasone and 4 mg of ondansetron were given IV for nausea 
prophylaxis.  
 The patient was positioned supine with arms secured on padded arm boards, prepped, and 
draped. A lower body Bair hugger was placed. Ten minutes after the incision was made the 
patient's blood pressure was 142/79 mmHg, subsequently 1 mg of hydromorphone IV was 
administered. Twenty-six minutes later her blood pressure was 152/83 mmHg, and heart rate was 
105 BPM. Therefore, an additional 1 mg of hydromorphone IV was administered. Ten 
milligrams of labetalol IV was administered for a blood pressure of 156/84 mmHg and a 
consistent sinus tachycardia with a heart rate of 110 BPM. Upon emergence the patient had 4/4 
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train of four with sustained tetany, the propofol infusion was turned off, and the patient was 
breathing spontaneously at 12-14 respirations per minute with tidal volumes of 400-500 mL, 
following commands and able to sustain a head lift greater than 5 seconds. Neuromuscular 
blockade reversal was not administered as patient met adequate extubation criteria and had 
received one dose of rocuronium that was 2 hours and 7 minutes earlier.  
 During the two-hour twenty-one-minute surgical case, the patient received a total of 
1,400 mL of lactated ringers. Estimated blood loss was 100 mL. The patient was admitted to a 
medical-surgical unit overnight; her pain was treated with morphine IV and 
acetaminophen/hydrocodone orally.  She was discharged home the following day. 
Literature Search 
Relevant articles were obtained through searches completed via the University of North 
Dakota's Health Sciences Library utilizing the CINAHL and PubMed databases. A MeSH 
Pubmed search for scholarly medical articles and research was conducted, where several useful 
articles were found. Keywords searched were: regional anesthesia, which prompted the use of 
“anesthesia, conduction”; other keywords were cancer and metastasis. The MeSH Pubmed 
search was anesthesia, conduction AND neoplasms AND neoplasm metastasis. This search 
resulted in 92 relevant articles and was then filtered for the past ten years and narrowed down to 
37 related articles. Nine articles will be used from the Pubmed database search. A search was 
also conducted on the CINAHL database for scholarly medical articles and research journals. 
Keywords used were: anesthesia, cancer, and metastasis, which resulted in 53 related articles 
from 2006-2017, and four articles will be used.  
Factors within the literature review included categories of anesthetic drugs such as 
volatile anesthetic gases, opioids and local anesthetics and their effect on cancerous cells and 
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studies relating to the effect of regional anesthesia on the metastasis of cancer. Reference lists of 
pertinent articles were also reviewed, which resulted in the use of 3 articles. Articles lacking 
adequate references and those not in the English language were excluded.  
Review of Literature 
Thoracic Paravertebral Block 
 Thoracic paravertebral block (TPVB) is a regional anesthetic technique used for thoracic 
and breast surgeries by injecting local anesthetic in the paravertebral space, near the point where 
the thoracic spinal nerves emerge from the intervertebral foramina (Cali, Biffoli, Francesconi, 
Patrella, & Buonomo, 2017). Use of TPVB has been shown to significantly reduce pain and 
opioid use, lower chronic pain occurrence by greater than 30%, as well as decrease post-
operative nausea and vomiting, and shortening hospital stays (Wardhan, 2015; Cali et al., 2017). 
The use of regional anesthesia-analgesia appears to attenuate perioperative immunosuppression 
and may minimize metastases (Cali et al., 2017).  
 The use of ultrasound imaging while performing thoracic paravertebral block has been 
associated with fewer complications compared to using landmarks alone (Pace et al., 2016). An 
ultrasound-guided technique provides direct visualization of the paravertebral space during the 
procedure, thereby reducing the risk of complications (Pace et al., 2016). Potential complications 
of TPVB include accidental pleural puncture, symptomatic pneumothorax, hypotension, 
bradycardia, and local anesthetic toxicity (Pace et al., 2016). A study conducted on the incidence 
of complications with ultrasound-guided TPVB revealed very few complications, where only six 
complications were noted in 856 patients (0.70%), none of which were a pneumothorax (Pace et 
al., 2016).   
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 When examining the financial aspect of using TPVB for mastectomies, Offodile et al. 
(2017) report a cost-effective analysis: 
Preoperative paravertebral blocks are a cost-effective strategy in reducing acute 
postoperative pain following mastectomy. Given that breast cancer is the most common 
malignancy afflicting women with 37-40% receiving mastectomy, preoperative 
paravertebral block should be considered where and when available. In a time where the 
American people and US health system are battling an opioid epidemic, cost-effective 
strategies that reduce postoperative pain are needed to improve public health. (p. 483) 
This study indicates a realistic perspective and supports the use of paravertebral blocks from a 
cost-effective point of view.  
Cancer Biology 
Common among all articles reviewed, was a discussion on the biology of cancer itself 
and what promotes growth and metastasis of cancer cells. Tedore (2015) states on a cellular 
level, the microenvironment of a tumor is made up of cancer cells and different types of 
inflammatory cells and mediators. Inflammatory cells and mediators promote cancer formation 
and its progression (Tedore, 2015). The “initiation” and first step in cancer is when there is 
damage to the DNA (Tedore, 2015). The second injury is called “promotion,” and can be 
triggered by several things including inflammation, injury or irritants (Tedore, 2015). During the 
promotion stage, there is an increase in inflammatory cells, release of chemical mediators and 
oxidative damage which makes it hard for the body to destroy the cancerous cells resulting in 
cellular proliferation (Tedore, 2015). Angiogenesis (formation of new vessels from existing 
endothelial cells) is critical for the survival and growth of tumor cells (Tedore, 2015). 
Cancer Promotion 
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Surgical stress affects the neuroendocrine response, suppresses the immune system, and 
lowers cell-mediated immunity (CMI) (Barela & Welliver, 2017). The degree of surgical stress 
can vary depending on how invasive the surgical procedure is (Barela & Welliver, 2017). 
Suppression of the immune system results in overproduction of stress hormones and increased 
inflammatory response (Tedore, 2015). Pain has also been shown to activate the body’s stress 
response and suppress CMI (Tedore, 2015). According to Tedore (2015):  
Pro-inflammatory cytokine concentrations and the duration of their elevation have been 
shown to be correlated with surgical insult, lasting as long as 3–5 days after surgery. Both 
experimental and clinical studies have shown that surgery inhibits T-cell, B-cell, and 
natural killer (NK) -cell function for days after a surgical insult. (p. 36) 
Natural killer cells are the bodies’ primary defense against cancer cells (Snyder & Greenburg, 
2010). During surgery there is also a large release of inflammatory mediators (IL-6 and TNF-α), 
this inflammatory storm suppresses CMI (NK, cytotoxic T, and dendritic cell activity), which is 
one of the body’s vital defense mechanisms against cancer (Xuan et al., 2015). Cell-mediated 
immunity does not eradicate the primary tumor, but if it is not suppressed, it may eliminate 
minimal residual disease, preventing metastasis and recurrence (Snyder & Greenburg, 2010). 
Pharmacology 
Volatile anesthetics such as inhalational agents and IV anesthetic agents including 
ketamine and thiopental used in general anesthesia have been shown to increase the destruction 
of immune cells such as natural killer cells and T-lymphocytes, which leads to tumor progression 
(Barela & Welliver, 2017). Beneficial properties of propofol, an IV anesthetic, have been shown 
to inhibit the enzyme matrix metalloproteinase (MMP), which reduces cancer cell proliferation 
(Barela & Welliver, 2017). Propofol also reduces inflammatory cytokines, preserving NK-cell 
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activity, and inhibiting cancer spread (Xuan et al., 2015). Propofol conjugates have been shown 
to inhibit cellular adhesion, migration, and apoptosis in breast cancer cells and have been looked 
at as a treatment for breast cancers (Snyder & Greenburg, 2010). 
Local anesthetics (LA) have shown to be beneficial in reducing the spread and growth of 
cancer cells (Barela & Welliver, 2017). At high concentrations, LA are known to be cytotoxic to 
the cancer cells, via necrosis or apoptosis (Xuan et al., 2015). Inhibition of cancer cell 
proliferation, migration, and invasion along with anti-inflammatory properties are among other 
benefits (Xuan et al., 2015). 
Perioperative and chronic administration of opioids has been shown to promote 
angiogenesis and immunosuppression resulting in tumor cell proliferation (Snyder & Greenburg, 
2010; Barela & Welliver, 2017). Fentanyl has been shown to inhibit natural killer cells (Barela & 
Welliver, 2017). Other evidence has suggested that at higher, more adequate pain-relieving doses 
opioids may show tumor-suppressive effects due to blocking pain and the stress response to 
surgery (Tedore, 2015).  
Research Trial Review 
An initial retrospective study was conducted on a group of patients by Exadaktylos, 
Buggy, Moriarty, Mascha, and Sessler (2006), who hypothesized the use of regional anesthesia 
combined with general anesthesia (GA) would have lower cancer recurrence and metastasis rates 
than GA with opioid administration. The first group of patients had surgery with a paravertebral 
nerve block combined with general anesthesia. The second group received general anesthesia 
and postoperative morphine analgesia. The percentage of recurrence and metastasis-free survival 
of the paravertebral nerve block group was 94% at 24 months and 94% at 36 months. Whereas 
REGIONAL ANESTHESIA AND BREAST CANCER RECURRENCE  13 
the group that received GA with morphine was 82% and 77% respectively. The magnitude of 
benefit seen in the results from this study prompted further research. 
Several similar retrospective studies have been conducted over recent years. Starnes-Ott, 
Goravanchi, and Meininger (2015) conducted a retrospective study comparing paravertebral 
combined with general anesthesia to general anesthesia alone and showed no statistical 
difference between the two groups. Tsigonis et al. (2016) conducted a retrospective study 
comparing patients who received only local or regional anesthesia and those who received 
general anesthesia. Follow up was performed five years after the initial surgery and patients from 
each anesthesia group were categorized into one of three groups: overall survival, disease-free 
survival, or local/regional recurrence. Results showed no significant differences between the two 
types of anesthesia. Cata et al. (2016) conducted a retrospective study comparing patients who 
received paravertebral block anesthesia to patients who were treated with opioid-based analgesia 
and found no statistical difference between recurrence of breast cancer at 5.8 and six years 
following the initial surgery. Among all retrospective studies in this review, pain control was 
better in those who received regional anesthesia with less opioid administration.  
 A study conducted by Chen et al. (2015) used perioperative propofol-paravertebral 
anesthesia (PPA) technique, which combines a paravertebral nerve block (PVB) with a propofol 
infusion. It is hypothesized that PPA demonstrates a lower incidence of chronic postsurgical pain 
with avoiding opioids and inhibits surgical suppression of cellular immunity. PPA elevates the 
number of NK cells and T cells to increase NK toxicity and augment cancer cell apoptosis. The 
use of propofol also reduces the expression of MMP. Chen et al. (2015) states: 
PPA participates in several bioprocesses in the development of breast cancer 
including inhibiting hypoxia-inducible factor activity, elevating serum 
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concentration of nitric oxide index, depression of neuroepithelial cell 
transforming gene 1 signal pathway, blocking the nuclear factor kappa B pathway 
following a decreased expression of MMP, increasing NK cytotoxicity, and 
affecting transforming growth factor-β-targeted ras and HER2/neu gene 
pathways. (p.8259) 
Therefore, supporting the hypothesis of beneficial use of PPA. Although results from this 
study did not show a difference in rates of recurrence or metastasis of breast cancer 
between the two groups, Chen et al. (2015), points out that the reviews of the 
bioprocesses relating PPA to alterations in the cell matrix which should not be ignored. 
Similar studies regarding the use of PPA have shown an improvement in the prognosis of 
breast cancer (Chen et al., 2015).  
 A randomized controlled trial was conducted by Karmakar et al. (2017) which divided 
patients up into 3 study groups: GA only with total intravenous anesthesia (TIVA); TIVA with a 
single-injection thoracic paravertebral block (TPVB) and placebo infusion for 72 hours 
postoperatively; and TIVA with continuous TPVB for 72 hours postoperatively. Neither local 
recurrence nor metastasis or mortality differed statistically with or without regional block 
compared to general anesthesia.  
 Buckley, McQuaid, Johnson, and Buggy (2014) conducted a study in which blood 
samples were examined from patients in the propofol-paravertebral block group and sevoflurane-
opioid anesthesia group. Serum samples were then analyzed for NK cells, NK cell activating 
receptors and cytokine production. Serum from the women who were randomly assigned to the 
PPA group maintained healthy donor NK anti-tumor cell activity compared to the women from 
the sevoflurane-opioid anesthetic group.  
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Discussion 
 The level of evidence is rather low considering most of the studies are retrospective 
studies and only one randomized control trial was included. One study noted a reportable 
difference in favor of regional anesthesia and a lower recurrence rate or metastasis of breast 
cancer compared to general anesthesia and use of opioids. Other studies reported no statistically 
significant difference between anesthetic techniques used. Other limitations include selection 
bias, different statistical analysis, heterogenicity in the type of anesthetic technique, and lack of 
information regarding tumor size, staging, the presence of mutations, and additional treatments 
such as chemotherapy or radiation (Perez-Gonzalez et al., 2017). In Starnes-Ott et al. (2015) 
study it was determined that patients who received paravertebral blocks had more advanced 
stages of cancer, more invasive treatments, longer surgery times and a lower BMI compared to 
the general anesthesia alone group. Many of the studies were underpowered and required a larger 
group of over 1000 participants to detect a difference (Karmakar et al., 2015). Patients who 
received regional anesthesia reported less severe chronic pain and experienced a better physical 
and mental state (Karmakar et al., 2015). Patients receiving regional anesthesia required a 
considerably less amount of opioids and experienced less postoperative nausea, vomiting, and 
unplanned overnight admissions (Tsigonis et al., 2016).  
 Findings from the studies completed to date are helpful for planning future studies and 
including important limitations and requirements. A prospective, randomized clinical trial (RCT) 
is currently being conducted of patients with breast cancer who are undergoing mastectomies or 
isolated lumpectomy with axillary node dissection. These patients will be randomly assigned to a 
thoracic epidural or paravertebral anesthesia/analgesia group or a general anesthesia and 
morphine group. The trial will follow-up with patients over a ten-year period to determine cancer 
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recurrence or metastasis (Starnes-Ott et al., 2015). The RCT (NCT00418457) is expected to 
finish recruiting in 2019 (Perez-Gonzalez et al., 2017).  
Conclusion 
After reviewing the literature, the data neither supports or refutes the use of regional 
anesthesia for reduction of cancer recurrence or metastasis. However, it has been shown that 
regional anesthesia may decrease inflammation by reducing surgical stress and preventing 
immune suppression. The use of regional anesthesia is associated with better pain control, and 
patients require fewer opioids in the perioperative and postoperative periods, thereby reducing 
the risk of nausea and vomiting.  
 Paravertebral nerve blocks have been shown to cause no harm and have been associated 
with a very low risk of complications. There is a minor difference between the cost of regional 
and general anesthetic. Some anesthesia providers may need further training on specific 
techniques of regional blocks if they do not frequently perform them. Surgeons performing the 
procedures should also be aware of the anesthetic techniques being used. Patients also need 
education on their anesthetic options as well as the risks and benefits before making their 
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